Aditxt
Price & Volume
Stats
See moreOpen | $0.09 |
Previous Close | $0.11 |
Day Range | $0.09-$0.13 |
52W Range | $0.10-$53,453.51 |
Market Cap | $95,625 |
Shares Short | 91,437 |
Financials
See moreRevenue (12 Mos) | $14,336 |
Revenue Growth (YoY) | 1,094.4% |
Gross Profit (12 Mos) | $2,852 |
Diluted EPS | -$1,380.80 |
News
See moreYahoo Finance • 10 hours ago
Pre Market Movers: GNTA, HCWC, ZCMD Set The Path
Yahoo Finance • last month
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
Yahoo Finance • 7 months ago
BC-Most Active Stocks
Yahoo Finance • 9 months ago
Aditxt subsidiary targets early 2026 FDA submission for immune therapy
About
CEO | Mr. Amro A. Albanna |
Address | 2569 Wyandotte Street, Mountain View, CA, United States, 94043 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 26 |